Long-term Duration of First-Line Axitinib Treatment in Advanced Renal Cell Carcinoma.
Rini BI, Gruenwald V, Jonasch E, Fishman MN, Tomita Y, Michaelson MD, Tarazi J, Cisar L, Hariharan S, Bair AH, Rosbrook B, Hutson TE.
Rini BI, et al. Among authors: bair ah.
Target Oncol. 2017 Jun;12(3):333-340. doi: 10.1007/s11523-017-0487-4.
Target Oncol. 2017.
PMID: 28361451